Safety and Tolerability of Nicotinamide Riboside in Heart Failure With Reduced Ejection Fraction

ATS Statement: Guidelines for the Six-Minute Walk Test

American Journal of Respiratory and Critical Care Medicine · 2002 · 10.8K citations

Medicine, Kinesiology, Physical Medicine +13

Randomized, Double-Blind, Placebo-Controlled, Pilot Trial of Infliximab, a Chimeric Monoclonal Antibody to Tumor Necrosis Factor-α, in Patients With Moderate-to-Severe Heart Failure

Eugene S. Chung, Milton Packer, Kim Hung Lo et al. · Circulation · 2003 · 1.6K citations

Pharmacy, Cardiology, Pharmacotherapy +12

Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: A report from the studies of left ventricular dysfunction (SOLVD)

Guillermo Torre‐Amione, Samir Kapadia, Claude R. Benedict et al. · Journal of the American College of Cardiology · 1996 · 1.2K citations

Medicine, Cardiology, Internal Medicine +12

Cytokines and Cytokine Receptors in Advanced Heart Failure

Anita Deswal, Nancy J. Petersen, Arthur M. Feldman et al. · Circulation · 2001 · 1K citations · Full text

Veterinary Medicine, Cardiology, Immunology +13

Nicotinamide riboside is uniquely and orally bioavailable in mice and humans

Samuel A.J. Trammell, Mark S. Schmidt, Benjamin J. Weidemann et al. · Nature Communications · 2016 · 708 citations · Full text

Life Sciences, Pharmacokinetics, Pharmacology +17